Skip to main content
logo
BioAtla, Inc. (BCAB)
OTCMKTS · Delayed Price · Currency is USD
1.080
-0.610 (-36.09%)
At close: Sep 1, 2026

BioAtla Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
8.5211--0.25
Revenue Growth
-22.73%-81.82%----41.73%
Gross Profit
-16.06-41.07-52.1-103.73-79.35-58.02
Operating Income
-31.03-58.71-73.94-129.69-108.14-96.44
Net Income
-31.45-59.61-69.78-123.46-106.48-95.4
Earnings Per Share
-22.74-50.66-71.83-129.21-136.77-138.02
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.547.1249.05111.47215.51244.98
Total Debt
5.866.20.842.463.985.37
Net Cash (Debt)
-4.320.9248.21109.01211.53239.61
Net Cash Growth
--98.10%-55.77%-48.46%-11.72%0.71%
Net Cash Per Share
-3.120.7849.63114.08271.69346.64

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-23.48-48.2-71.94-104.02-90.42-62.21
Capital Expenditures
----0.1-0.27-0.92
Free Cash Flow
-23.48-48.2-71.94-104.11-90.69-63.14
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-188.92%-----
Operating Margin
-365.00%-2935.25%-672.21%---38576.00%
Pretax Margin
-370.05%-2980.35%-634.33%---38160.80%
Profit Margin
-370.05%-2980.35%-634.33%---38160.80%
FCF Margin
-276.26%-2410.20%-653.96%---25255.20%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.2116.763.12--8633.02